Pregnolia

Bruno Candrian explains how Pregnolia improves medical support during pregnancy.

Pregnolia has developed a device that supports the diagnosis of premature birth. It enables gynaecologists to measure cervical stiffness more precisely and thus make a better assessment of the risk of premature birth. SwissHealth Ventures invested in this ETH spin-off in 2020 in the series A round (which raised a total of CHF 4.2 million in funding from all investors).

SwissHealth Ventures believes in the success of the Pregnolia measurement system and its ability to provide great reassurance to professionals and pregnant women. We also believe that this method will reduce healthcare costs in the long term.